Literature DB >> 29753795

Nonanesthetic Effects of Ketamine: A Review Article.

Jabril Eldufani1, Alireza Nekoui2, Gilbert Blaise3.   

Abstract

Ketamine is considered a dissociative anesthetic medication, and it is commonly administered by a parenteral route. It works mainly by blocking the N-methyl-D-aspartate receptor. It inhibits the voltage-gated Na and K channels and serotonin and dopamine reuptake; also, it affects specific receptors, such as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, kainate, and aminobutyric acid A receptors. Ketamine appears to have particular mechanisms that are potentially involved during analgesic induction, including enhancing of descending inhibition and antiinflammatory effects. More recently, it has been shown that ketamine has potential in clinical practice for the management of chronic pain, cognitive function, depression, acute brain injury, and disorders of the immune system.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain injury; Chronic pain; Depression; Immune system; Ketamine; N-methyl-d-aspartate receptor antagonist

Mesh:

Substances:

Year:  2018        PMID: 29753795     DOI: 10.1016/j.amjmed.2018.04.029

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.

Authors:  Gustavo C Medeiros; Todd D Gould; William L Prueitt; Julie Nanavati; Michael F Grunebaum; Nuri B Farber; Balwinder Singh; Sudhakar Selvaraj; Rodrigo Machado-Vieira; Eric D Achtyes; Sagar V Parikh; Mark A Frye; Carlos A Zarate; Fernando S Goes
Journal:  Mol Psychiatry       Date:  2022-06-27       Impact factor: 15.992

2.  Ketamine Mitigates Neurobehavioral Deficits in a Canine Model of Hypothermic Circulatory Arrest.

Authors:  Katherine Giuliano; Eric Etchill; Ana K Velez; Mary Ann Wilson; Mary E Blue; Juan C Troncoso; William A Baumgartner; Jennifer S Lawton
Journal:  Semin Thorac Cardiovasc Surg       Date:  2022-01-05

3.  Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.

Authors:  David G Vossler; Jacquelyn L Bainbridge; Jane G Boggs; Edward J Novotny; Tobias Loddenkemper; Edward Faught; Marta Amengual-Gual; Sarah N Fischer; David S Gloss; Donald M Olson; Alan R Towne; Dean Naritoku; Timothy E Welty
Journal:  Epilepsy Curr       Date:  2020-08-21       Impact factor: 7.500

4.  Evaluation of Clinical Factors Associated with Adverse Drug Events in Patients Receiving Sub-Anesthetic Ketamine Infusions.

Authors:  Alexander D Stoker; David M Rosenfeld; Matthew R Buras; Jeremy M Alvord; Andrew W Gorlin
Journal:  J Pain Res       Date:  2019-12-23       Impact factor: 3.133

5.  Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice.

Authors:  Po-An Chen; Hui-Yi Wang; Chien-Lun Sun; Mao-Liang Chen; Yi-Chyan Chen
Journal:  Behav Neurol       Date:  2022-02-23       Impact factor: 3.342

6.  Effects of low-dose ketamine infusion on remifentanil-induced acute opioid tolerance and the inflammatory response in patients undergoing orthognathic surgery.

Authors:  Kanta Kido; Shinichi Toda; Yuki Shindo; Hitoshi Miyashita; Shigekazu Sugino; Eiji Masaki
Journal:  J Pain Res       Date:  2019-01-17       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.